|
Post by selluwud on Jul 20, 2020 15:40:37 GMT
This company is in a collaboration with Dyadic. Also write up in Wall St Journal,there is no mention of DYAI, but I thought if may be relevant.
|
|
|
Post by JHam on Jul 20, 2020 16:23:20 GMT
This company is in a collaboration with Dyadic. Also write up in Wall St Journal,there is no mention of DYAI, but I thought if may be relevant. Which company?
|
|
|
Post by selluwud on Jul 20, 2020 17:46:12 GMT
|
|
|
Post by selluwud on Aug 14, 2020 17:54:51 GMT
|
|
|
Post by lcd on Oct 12, 2020 13:41:49 GMT
|
|
|
Post by selluwud on Dec 9, 2020 20:25:38 GMT
Whoa, anybody seeing this. Something's stirring the pot!
|
|
|
Post by selluwud on Dec 9, 2020 20:28:58 GMT
Fox Business channel interview in progress. I'm recording for later viewing.
|
|
|
Post by JHam on Dec 10, 2020 4:11:19 GMT
Fox Business channel interview in progress. I'm recording for later viewing. I didn't see the interview, but what a wild whirlwind of a day that was.
|
|
|
Post by selluwud on Dec 10, 2020 13:00:25 GMT
Fox Business channel interview in progress. I'm recording for later viewing. I didn't see the interview, but what a wild whirlwind of a day that was. Yep, at the beginning of the interview Mark mentioned they could produce a billion vaccine doses in short order, he never actually says their methodology has been approved for human use as of yet. He sends a lot of cryptic messages with what can be in the future, but not a lot of new information about progress.
|
|
|
Post by JHam on Dec 10, 2020 14:46:46 GMT
I didn't see the interview, but what a wild whirlwind of a day that was. Yep, at the beginning of the interview Mark mentioned they could produce a billion vaccine doses in short order, he never actually says their methodology has been approved for human use as of yet. He sends a lot of cryptic messages with what can be in the future, but not a lot of new information about progress. He is walking a fine line with his comments. I imagine he is frustrated. If C1 isn’t getting used in this moment, a moment that is was supposed to have been made for, then I’m not sure where it fits in. Especially with Moderna and their mRNA approach moving full steam ahead. Mark needs to make a deal soon.
|
|
|
Post by lcd on Feb 2, 2021 22:30:01 GMT
|
|
|
Post by selluwud on Feb 12, 2021 19:06:29 GMT
I've been holding here for what seemed to be chance for a buy out or deal for their tech. The Covid epidemic only made sense to push up any developments that may be in the cards. Tradewinds Research dropped their interest due to inactivity/news. It is making a nice run today on no news with average volume. I've been debating selling due to the perceived stagnation, but then again, fear of missing out doesn't escape me.
|
|
|
Post by JHam on Mar 22, 2021 12:38:19 GMT
Finally some news here. Not sure how substantive it is though: finance.yahoo.com/news/dyadic-medytox-develop-vaccines-against-123000403.htmlDyadic and Medytox To Develop Vaccines Against COVID-19 VariantsExpanding existing COVID-19 vaccine research collaboration which began in July 2020.
Medytox and Dyadic to co-develop C1 enabled COVID-19 vaccines and/or boosters which will immunize people against two or more of the current and future COVID-19 variants (e.g., tetravalent or quadrivalent COVID-19 vaccines)
Exclusive license for Republic of Korea and multiple Southeast Asian countries, if successful
Manufacturing protocols to produce vaccines from C1 have been successfully transferred and reproduced at Medytox
|
|
|
Post by lcd on Mar 22, 2021 13:04:05 GMT
I have been sitting in red on a lot of DYAI shares and I am probably wrong on this analysis, but it spiking almost 40% on this news doesn't seem like something that will last so I sold about 50% of my position this morning. I still own a good bit of DYAI and think they have tons of potential but they seemed to miss too many opportunities last year.
|
|
|
Post by selluwud on Mar 22, 2021 13:04:08 GMT
I'm still sitting on a pile of shares here pondering whether to sell into this news or just keep holding for future developments???
|
|
|
Post by selluwud on Mar 22, 2021 13:21:09 GMT
I have been sitting in red on a lot of DYAI shares and I am probably wrong on this analysis, but it spiking almost 40% on this news doesn't seem like something that will last so I sold about 50% of my position this morning. I still own a good bit of DYAI and think they have tons of potential but they seemed to miss too many opportunities last year. I followed your lead and sold half my position. Most likely this will fade back to a trading range I can re-enter with.
|
|
|
Post by lcd on Mar 22, 2021 13:23:34 GMT
When it crossed $7.50 I sold the rest of my shares so selluwud you can expect the pps to double once regular trading hours start because that is how it works when I sell.
|
|
|
Post by selluwud on Mar 22, 2021 14:03:31 GMT
When it crossed $7.50 I sold the rest of my shares so selluwud you can expect the pps to double once regular trading hours start because that is how it works when I sell. I know you're glad to get out green!! I think this will sink on the next NASDAQ down cycle as the tech market seems to be way overvalued
|
|
|
Post by lcd on Mar 22, 2021 14:49:19 GMT
For once my sell early plan worked out reasonably well. The price did briefly jump over $8.40 minutes before pre-market ended but I still got out with a nice 40%+ profit. I will keep tracking this stock because I think it could be a disruptive technology, but they just seem to struggle to get their foot in the door.
|
|
|
Post by JHam on Mar 22, 2021 15:19:18 GMT
For once my sell early plan worked out reasonably well. The price did briefly jump over $8.40 minutes before pre-market ended but I still got out with a nice 40%+ profit. I will keep tracking this stock because I think it could be a disruptive technology, but they just seem to struggle to get their foot in the door. Wow, nice job!
|
|